Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Transgender Women: early-phase trial registry
2 of 4 indexed Transgender Women trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Transgender Women: 4 US clinical trials tracked, 2 recruiting.
Transgender Women is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Central Florida, running 2 of these trials.
Enrollment posture brief
Registry condition transgender-women
OPEN 2 | RECR 50% | LATE 0 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Transgender Women lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Transgender Women on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Transgender Women is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
University of Central Florida
NCT06202898
Progesterone in Gender Affirming Hormone Therapy Study
Emory University
NCT06807580
To Reach Unrestricted Services for Transgender Women
University of Central Florida
NCT03877497
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
Thomas Jefferson University
NCT04283656
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Transgender Women records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Transgender Women trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Transgender Women page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Transgender Women trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Central Florida sponsors the most Transgender Women trials on record, review their full trial history before evaluating a specific study. See University of Central Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transgender Women condition card totals 4 registered trials; most-linked intervention Estradiol 2mg; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.